Nile L. Albright M.D.

Dr. Albright retired from medical practice in 2014. Since retiring, his dedication to research continues through the activity of the Foundation and its ongoing efforts to improve treatment and cures for cancer.

  • Facebook
  • Twitter

Bio

Dr. Nile Albright spent more than four decades helping patients as a general surgeon in Boston, pushing for cures for cancer through his research initiatives and promoting science education in local schools in New England. Dr. Albright has practiced at Massachusetts General Hospital, the National Institute of Health, Baptist and Deaconess Hospitals and in private surgical practice. 

 

In 1974 Dr. Albright founded the Advanced Medical Research Foundation (AMRF), renamed in 2021 to the Nile Albright Research Foundation, a 501(c)(3) public foundation that fulfills Dr. Albright’s lifelong passion and commitment for the search for cures for Cancer.
 

Dr. Albright is a member of the Board of Overseers at The Museum of Science and has been a trustee of the Norman H Read Trust since 1992. Through the Read Trust he has directed funds towards science education in the elementary schools and high school in Salem for over 25 years. In addition, Dr. Albright founded the Albright Read Institute (ARI) at North Shore Medical Center for the advancement of medical science to
help the health and well-being of Salem residents. He received the LEAP for Education 2018 Distinguished Leader award for his commitment to the students of Salem.

 

Nile L. Albright is a graduate of Harvard College ’61, a Harvard Scholar to Cambridge University ‘62 and a graduate of the College of Physicians and Surgeons, Columbia University ’67. He was a resident at Massachusetts General Hospital and a fellow at the National Institute of Health before joining his father and sister in their Boston private medical practice. He retired from practice in 2014. Since retiring from the practice of medicine, his dedication to research continues through the activity of the Foundation and its ongoing efforts to improve treatment and cures for cancer.